Pulmonary Diseases Completed Phase 4 Trials for Ciprofloxacin (DB00537)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00367913Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary DiseaseTreatment